CD40-CD40L has been associated with type 2 diabetes mellitus46, VEGF is involved in the pathogenesis of diabetic complications47, c-Kit and its ligand, stem cell factor (SCF) have been reported as a potential novel target for treating diabetes48. This evidence concerns the gene KIT and type 2 diabetes mellitus.